New drug combo shows promise for tough lung cancers
NCT ID NCT03003468
First seen Jan 23, 2026 · Last updated May 22, 2026 · Updated 19 times
Summary
This study tested a combination of two drugs, pembrolizumab and Imprime PGG, in 35 adults with advanced non-small cell lung cancer that had worsened after first-line therapy. The goal was to find the best dose and see if the combination could slow cancer growth. The study was completed and measured side effects and how long patients lived without their cancer getting worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Indiana Univeristy Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, 46202, United States
-
Penn State Cancer Institute
Hershey, Pennsylvania, 17033, United States
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08903, United States
-
University of Illinois at Chicago
Chicago, Illinois, 60612, United States
-
University of Iowa Hospital and Clinics
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.